Financial statements Bio Herbs
Balance sheet data of BIO HERBS
|
Year
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 1 587 116,73 | 3 184 433,88 | 4 789 602,12 | 8 165 102,79 | 8 840 655,20 |
| A. Fixed assets | 900 771,72 | 1 339 669,53 | 2 224 674,21 | 3 759 448,55 | 3 429 895,23 |
| B. Current assets | 686 345,01 | 1 844 764,35 | 2 564 927,91 | 4 405 654,24 | 5 410 759,97 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | - |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | - |
| Total liabilities | 1 587 116,73 | 3 184 433,88 | 4 789 602,12 | 8 165 102,79 | 8 840 655,20 |
| A. Equity | 62 358,19 | 969 304,57 | 2 153 757,63 | 3 326 457,32 | 4 642 766,73 |
| B. Liabilities and provisions for liabilities | 1 524 758,54 | 2 215 129,31 | 2 635 844,49 | 4 838 645,47 | 4 197 888,47 |
| I. Long-term liabilities | 0,00 | 1 548 500,00 | 2 415 438,09 | 3 155 838,08 | 2 209 504,00 |
| II. Short-term liabilities | 1 524 758,54 | 666 629,31 | 220 406,40 | 183 554,72 | 397 738,72 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.